Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer

Glioblastoma (GBM) remains the most frequently diagnosed primary malignant brain cancer in adults. Despite recent progress in understanding the biology of GBM, the clinical outcome for patients remains poor, with a median survival of approximately one year after diagnosis. One factor contributing to...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbaniak, Alicja, Reed, Megan R., Heflin, Billie, Gaydos, John, Piña-Oviedo, Sergio, Jędrzejczyk, Marta, Klejborowska, Greta, Stępczyńska, Natalia, Chambers, Timothy C., Tackett, Alan J., Rodriguez, Analiz, Huczyński, Adam, Eoff, Robert L., MacNicol, Angus M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472755/
https://www.ncbi.nlm.nih.gov/pubmed/36076555
http://dx.doi.org/10.1016/j.biopha.2022.113440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472755/
https://www.ncbi.nlm.nih.gov/pubmed/36076555
http://dx.doi.org/10.1016/j.biopha.2022.113440

Ejemplares similares